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Abstract
Background Increasing numbers of people are undergoing
bariatric surgery, of which approximately half are women in
their childbearing years. However, information on the long-
term effects of maternal bariatric surgery in their children is
lacking. Furthermore, since bariatric surgery is performed to
reduce body weight, clinical studies have not been able to
differentiate between benefits to the child due to maternal
body weight loss versus other maternal postoperative meta-
bolic changes. Therefore, we used the University of
California, Davis, type 2 diabetes mellitus (UCD-T2DM) rat
model to test the hypothesis that maternal ileal interposition
(IT) surgery would confer beneficial metabolic effects in
offspring, independent of effects on maternal body weight.
Methods IT surgery was performed on 2-month-old predia-
betic female UCD-T2DM rats. Females were bred 3 weeks
after surgery, and male pups were studied longitudinally.
Results Maternal IT surgery resulted in decreased body weight
in offspring compared with sham offspring (P <0.05). IT off-
spring exhibited improvements of glucose-stimulated insulin
secretion and nutrient-stimulated glucagon-like peptide-2
(GLP-2) secretion (P <0.05). Fasting plasma unconjugated bile
acid concentrations were 4-fold lower in IToffspring compared
with sham offspring at two months of age (P <0.001).
Conclusions Overall, maternal IT surgery confers modest im-
provements of body weight and improves insulin secretion
and nutrient-stimulated GLP-2 secretion in offspring in the
UCD-T2DM rat model of type 2 diabetes, indicating that this
is a useful model for investigating the weight-independent
metabolic effects of maternal bariatric surgery.
Keywords Ileal interposition .Maternal effects .
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Introduction
With the increased worldwide prevalence of obesity and type 2
diabetes, the development of therapeutic strategies to prevent or
delay the onset of diabetes in predisposed individuals has
become increasingly urgent [1]. In particular, the prevalence
of obesity in women of reproductive age in the USA is greater
than 30 %, and the prevalence of obesity among children and
adolescents has increased bymore than 11% between 1994 and
2000 [2]. Several clinical studies have demonstrated that ma-
ternal obesity during gestation increases the risk of developing
obesity and type 2 diabetes in children [3, 4]. Bariatric surgery
is currently the most effective long-term treatment for obesity
and often results in rapid resolution of type 2 diabetes [5, 6].
Thus, there are increasing numbers of people undergoing bar-
iatric surgery, of whom approximately half are women in their
childbearing years [7]. Specifically, more than 150,000 women
of reproductive age underwent bariatric surgery between 2005
and 2008 [7]. Epidemiological data suggest that the risk of
maternal and neonatal complications, such as gestational dia-
betes and low birth weight, are reduced in mothers who have
undergone bariatric surgery prior to pregnancy [7]. Clinical
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studies report on decreased incidence of obesity, improved
insulin sensitivity, and decreased circulating lipids and markers
of inflammation in children born to mothers after bariatric
surgery compared with siblings born to the same mothers prior
to bariatric surgery, providing a potentially valuable model for
the identification and development of new preventative and
therapeutic strategies for addressing metabolic diseases [8, 9].
One important question that has not been addressed is the
impact of postoperative maternal metabolic changes on the
child, independent of maternal body weight loss. The negative
impact of obesity during gestation and the positive impact of
weight loss prior to pregnancy have been supported by mul-
tiple studies [2, 4, 7, 10, 11]. Since bariatric surgery is primar-
ily performed to reduce body weight, clinical studies have not
been able to differentiate between benefits to the child due to
maternal body weight loss versus maternal postoperative met-
abolic and endocrine changes.
Roux-en-Y gastric bypass (RYGB) surgery is one of the most
common clinically performed bariatric surgeries [12]. RYGB
involves several postoperative alterations in normal GI anatomy
and function, such as reduction in gastric volume, bypass of the
proximal small intestine, and increased flux of incompletely
absorbed nutrients into the distal small intestine. In contrast, ileal
interposition (IT) surgery only involves movement of a segment
of distal small intestine into the proximal jejunum [13]. Similar to
RYGB, IT surgery results in increased circulating bile acid
concentrations and increased nutrient-stimulated glucagon-like
peptide-1 (GLP-1) secretion [14, 15]. Unlike RYGB, IT surgery
does not decrease food intake or result in a loss of body weight.
Therefore, IT surgery provides an ideal surgical model for study-
ing the effects of postoperative maternal metabolic changes on
the offspring, independent of changes of maternal body weight.
We have previously demonstrated that ITsurgery in polygenic
obese University of California, Davis, type 2 diabetes mellitus
(UCD-T2DM) rats results in a 4-month delay (equivalent to
10 years in a human lifespan) in the onset of type 2 diabetes,
independent of changes of body weight [14]. The UCD-T2DM
rat model develops adult-onset polygenic obesity, insulin resis-
tance, and hyperglycemia, without a defect in leptin signaling, in
both genders, making this model ideal for the study on the
metabolic effects of maternal bariatric surgery on type 2 diabetes
risk [16]. Thus, the purpose of the current study was to perform
an initial investigation of the hypothesis that maternal IT surgery
would confer beneficial metabolic effects in offspring, indepen-
dent of effects on maternal body weight.
Materials and Methods
Diets and Animals
UCD-T2DM rats were individually housed in hanging wire
cages in the animal facility in the Department of Nutrition at
the University of California, Davis, and maintained on a
14:10-h light–dark cycle. Weight-matched female UCD-
T2DM rats underwent IT or sham surgery (n =4 per group)
at 2 months of age with an average body weight of 232±5 g.
Female siblings were studied with one being sham-operated
and the other being IT-operated. Three weeks after surgery,
females were mated to unoperated male siblings. Similar to
our previous study in UCD-T2DM rats [14], body weight did
not differ between IT- and sham-operated dams (Table 1).
Litters were culled such that the number of pups per litter
within each cohort was matched in order to control for nutrient
intake during the nursing period. After weaning, the male
offspring were studied, resulting in an average of 4±1 off-
spring studied per litter. All animals received ground rodent
chow (no. 5012, Ralston Purina, Belmont, CA). Food intake
and body weight were measured three times a week. Monthly
fasting blood samples were collected, and an oral glucose
tolerance test (OGTT) was performed at 4 months of age.
The experimental protocols were approved by the UC Davis
Institutional Animal Care and Use Committee.
Ileal Interposition Surgery
IT surgery was performed as previously described [14]. Rats
were placed on a liquid diet (Boost®, Novartis, Minneapolis,
MN) 4 days prior to surgery and for 7 days postsurgery and
received enrofloxacin (20 mg/kg/day, s.c.) before and after
surgery. Anesthesia was induced and maintained with
isoflurane (2–5 %). A midline abdominal incision was made,
and a 10-cm segment of distal small intestine 5–10 cm prox-
imal to the ileocecal valve was isolated and transected. An
anastomosis was made with the remaining ends of the ileum
using 7-0 PDS suture (Ethicon®). Next, a transection was
made 5–10 cm distal to the ligament of Treitz. The isolated
ileal segment was then inserted isoperistaltically. Sham-
operated animals were treated in the same manner as the IT
group. Sham surgeries were performed by making transec-
tions in the same locations as in the IT-operated animals, and
bowels were reattached by anastomosis in their original
position.
Table 1 Dam body weight






Values expressed as mean ± SEM. n =4
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Hormone and Metabolite Measurements
Fasting (13 h) plasma samples were collected from offspring
starting at 2 months of age up to 6 months of age into EDTA-
treated tubes. Plasma glucose, cholesterol, and triglycerides
(TG) were measured using enzymatic colorimetric assays
(Thermo DMA Louisville, CO; L-type TG H kit). Insulin was
measured with a rat specific RIA (Millipore, St. Charles, MO).
Oral Glucose Tolerance Test
At 4 months of age, an OGTT was performed on offspring.
Animals were fasted overnight and then received a 50 %
dextrose solution (1 g/kg BW) by oral gavage. Blood was
collected from the tail and placed in tubes containing EDTA,
aprotinin, and a DPP-IV inhibitor. Plasma glucose and insulin
were measured as described above. Total GLP-1 was mea-
sured by sandwich electrochemiluminescence immunoassay
(Meso Scale Discovery; Gaithersburg, MA). Total GLP-2 was
measured by ELISA (Millipore, St. Charles, MO).
Monthly Fasting Plasma Bile Acid Profiles
Monthly bile acid profiles were analyzed as previously de-
scribed [17, 18]. An internal standard mixture of D4-cholate,
D4-β-muricholate, D4-a-muricholate, D4-chenodeoxycholate,
D4-deoxycholate, D4-hyodeoxycholate, D4-ursodeoxycholate,
and D4-lithocholate and their tauroconjugated and
glycoconjugated counterparts was prepared in acetonitrile.
Eluted bile salts were detected by negative-ion electrospray
mass spectrometry on a linear trap LTQ mass spectrometer
(Thermo-Finnigan, San Jose, CA) using a data-dependent stage
of detection triggering a qualitative 0 m /z neutral loss scan at
27 % normalized collision energy. Peak areas from initial scans
of individual bile salts at 514.3, 498.3, 464.3, 447.3, 411.3,
407.3, 395.3, 393.3, and 391.3 m /z were integrated, and re-
sponse factors were defined by peak area ratios of analytes to
that of internal, deuterated standards. The response factors were
read against those obtained from standard curves in surrogate
matrix, and molar levels of serum or plasma levels were inter-
polated from standard curves. Response factors for all sam-
ples were comprised of peak area ratios of non-labeled
salts normalized to the stably labeled counterparts.
Concentrations were interpolated by linear regression
from curves of known standards.
Statistics and Data Analyses
All male offspring from each litter were enrolled into study,
resulting in a total of 21 male IT offspring and 18 male sham
offspring being studied. However, in all data sets, the average
of the data points from animals in the same litter was used for
statistical analysis and presentation of the data, resulting in an
n of 4 per group. This is because the experimental variable
being tested in this study is the impact of surgery in the dam
and presumably on the in utero and preweaning environment
on the offspring from each litter. All statistical analyses were
performed using GraphPad Prism 4.00 for Windows
(GraphPad Software, San Diego, CA). Data were analyzed
using two-factor repeated measures ANOVA or Student’s t
test where appropriate. Data are presented as mean ± SEM.
Differences were considered significant at P <0.05.
Results
Maternal IT Surgery Reduces Body Weight in Offspring
Food intake did not differ between groups by two-factor
repeated measures ANOVA (Fig. 1a). However, cumulative
food intake between 4 and 6 months of age was 10% lower in
IT offspring compared with sham offspring (cumulative food
intake: sham offspring=2,064±112 g, IT Offspring=1,840±
100 g; P <0.05). Body weight was significantly lower in IT
offspring compared with sham offspring at as early as 1 month
of age (sham offspring=105±3 g; IT Offspring=96±3 g; P <
0.05). Body weight continued to be approximately 5 % lower
in IT offspring from 2 months of age to 6 months of age (BW
at 2 months of age: sham offspring=379±4 g, IT offspring=
358±4 g; P <0.05) (Fig. 1b).
Maternal IT Surgery Does Not Affect Fasting Plasma Glucose
and Insulin Concentrations in Offspring
Fasting plasma glucose concentrations tended to be lower in
IT offspring compared with sham offspring at 2, 5, and
6 months of age (Fig. 2a). This was significant by Student’s
t test at 2 months of age (P <0.05) but was not significant by
two-factor repeated measures ANOVA. Fasting plasma insu-
lin concentrations were 40 % lower in IT offspring compared
with sham offspring at 2 months of age (Fig. 2b). This was
also significant by Student’s t test (P <0.05), but not by two-
factor repeated measures ANOVA. Surprisingly, IT offspring
exhibited a trend for increased circulating TG and cholesterol
concentrations (Fig. 2c, d).
Maternal IT Surgery Improves Insulin Secretion
and Nutrient-Stimulated GLP-2 Secretion in Offspring
In order to further investigate the metabolic effects of maternal
IT surgery, an OGTTwas performed at 4 months of age. The
glucose and insulin area under the curve (AUC) during the
OGTT did not differ between groups (glucose AUC: sham
offspring=23,274±775 mg/dl×120 min, IT offspring=
22,775±900 mg/dl×120 min; Insulin AUC: sham off-
spring=464±82 ng/ml×120 min, IT offspring=486±36 ng/
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ml×120 min) (Fig. 3a, b). However, the percent increase of
plasma insulin concentrations from fasting to peak values at
30 min after the glucose gavage was ∼30 % higher in IT
offspring compared with sham offspring, indicative of an
improvement of glucose-stimulated insulin secretion in IT
offspring (P <0.05) (Fig. 3b). Plasma total GLP-1 excursions
tended to be increased in IT offspring compared with sham
offspring; however, this did not reach significance (GLP-1
AUC: sham offspring=1,038±149 pg/ml×60 min, IT off-
spring=1,194±150 pg/ml×60 min) (Fig. 3c). GLP-2 concen-
trations at 15 min following the glucose gavage were 40 %
higher in IT offspring, and the GLP-2 AUC was 23 % higher
in IT offspring compared with sham offspring (GLP-2 AUC:
sham offspring=85±6 pg/ml×60 min, IT offspring=104±
8 pg/ml×60 min; P <0.05) (Fig. 3d).
Maternal IT Surgery Decreases Circulating Unconjugated
Bile Acid Concentrations in Offspring
Circulating bile acid concentrations have been reported to be
elevated after several types of bariatric surgery including
RYGB, IT, and vertical sleeve gastrectomy [14, 19–21].
Fig. 1 Food intake (a) and body weight (b) in sham and IT offspring. *P <0.05 by two-factor repeated measures ANOVA
Fig. 2 Fasting plasma glucose (a), insulin (b), triglyceride (c), and cholesterol (d) concentrations in sham and IT offspring
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These increases of circulating bile acids have been proposed
to contribute to the metabolic benefits observed after bariatric
surgery [19, 20]. Therefore, we assessed circulating bile acid
profiles over time in sham and IToffspring. Interestingly, total
circulating bile acid concentrations were 80 % lower in IT
offspring compared with sham offspring at 2 months of age
(Fig. 4a) (P <0.001). Bile acid concentrations then dropped in
sham offspring to levels similar to IT offspring starting at
3 months of age. Total plasma conjugated bile acid concen-
trations did not differ between groups (Fig. 4b), but total
plasma unconjugated bile acid concentrations were only
25 % of that in IT offspring, mimicking the same pattern seen
in total circulating bile acid concentrations over time
(P <0.001) (Fig. 4c).
Conclusions
Overall, there is little information on the short and long-term
effects of maternal bariatric surgery on offspring.
Furthermore, most of the available data are confounded by
the potential effects of maternal weight loss after bariatric
surgery. This is the first study to evaluate the effect of the
metabolic changes induced by only one component of Roux-
en-Y gastric bypass surgery (moving the distal small intestine
proximally) on offspring. This approach allows us to investi-
gate the metabolic effects of maternal distal intestinal stimu-
lation with incompletely absorbed nutrients on offspring with-
out confounding differences in maternal body weight. In this
initial study, we found that maternal IT surgery imparts reduc-
tions of body weight and improvements of insulin secretion
and nutrient-stimulated GLP-2 secretion, independent of dif-
ferences in maternal body weight.
Maternal IT surgery resulted in significant decreases of
body weight in offspring. However, food intake only differed
significantly between groups when comparing cumulative
food intake between 4 and 6 months of age. This suggests
that IT offspring may have increased energy expenditure
compared with sham offspring. These results are consistent
with previous human clinical studies. Children born after
maternal biliopancreatic surgery exhibit lower birth weights
and a lower incidence of obesity [8, 9]. However, in these
previous studies, substantial maternal body weight loss oc-
curred prior to pregnancy. Thus, this is the first study to
Fig. 3 Plasma glucose (a), insulin (b), GLP-1 (c), and GLP-2 (d )
concentrations during an oral glucose tolerance test. Animals were fasted
overnight and received a 1-g/kg body weight dose of dextrose by oral
gavage. +P<0.05 for the percent change of plasma insulin concentrations
from baseline to peak values compared with sham offspring by Student’s
t test. *P<0.05 for the AUC compared with sham offspring by Student’s
t test
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provide data that suggest that the metabolic effects of maternal
bariatric surgery alone may be sufficient to produce decreases
of body weight in offspring.
Maternal IT surgery also resulted in a modest improvement
of glucose-stimulated insulin secretion. Previous studies have
demonstrated that the intrauterine environment plays a crucial
role in the development of the pancreatic islets. In particular, a
previous work by Sandovici et al. demonstrated that exposure
to suboptimal nutrition during early development of chow-fed
Wistar rats results in development of diabetes and is related to
epigenetic silencing of the enhancer region of the promoter for
the HNF-α gene, which is required forβ-cell proliferation [22].
Postoperative increases of postprandial GLP-1 secretion
have been suggested to contribute to the metabolic improve-
ments observed after bariatric surgery, and we hypothesized
that these increases may be conferred to the offspring [23, 24].
GLP-1 acts to increase glucose-stimulated insulin secretion,
inhibit glucagon secretion, decrease food intake, and may also
promote β-cell proliferation [25–28]. While there was a trend
for IT offspring to exhibit increases of nutrient-stimulated
GLP-1 secretion during the OGTT, this difference did not
reach significance. However, nutrient-stimulated GLP-2 se-
cretion was significantly elevated in IT offspring compared
with sham offspring. GLP-2 is produced and secreted from the
same gut enteroendocrine L cells as GLP-1 and acts to stim-
ulate proliferation of intestinal cells and thusmay contribute to
an increase in intestinal L cell number [29]. Nutrient-
stimulated GLP-2 secretion has been shown to be elevated
after IT and vertical sleeve gastrectomy surgery in rats and
early after RYGB and VSG in humans [30–32]. Therefore,
increases of nutrient-stimulated GLP-2 secretion in IT-
operated dams may have been conferred to the offspring.
Interestingly, Shen et al. reported that, in rats, feeding
dietary-resistant starch to mothers results in increased circu-
lating GLP-1 concentrations in the mothers and improved
fasting plasma glucose and increased circulating GLP-1 con-
centrations in offspring, suggesting that increases of maternal
gut hormones can be conferred to offspring, perhaps by an
epigenetic mechanism(s) [33].
The trend for maternal IT surgery to increase circulating
cholesterol concentrations was surprising and is in contrast to
previous studies demonstrating that maternal bariatric surgery in
humans results in decreases of circulating lipids in the subsequent
generation [9]. These conflicting data suggest that the effect of
maternal bariatric surgery to reduce circulating lipid concentra-
tions in offspringmay be related tomaternal bodyweight loss and
not to the effect of postoperative maternal metabolic changes.
Postoperative increases of circulating bile acid concentrations
have become a popularly cited mechanism for the metabolic
benefits observed after several types of bariatric surgery [20,
21, 23]. Bile acids have been shown to decrease hepatic gluco-
neogenesis and lipogenesis and increase insulin-mediated glu-
cose disposal in adipocytes by signaling through farnesoid X
receptor [34]. Bile acids have also been shown to signal through
TGR5 receptors located in the distal small intestine to increase
GLP-1 secretion and in TGR5 receptors on skeletal muscle and
brown adipose tissue to increase energy expenditure [34, 35].
Therefore, we investigated changes of circulating bile acid
Fig. 4 Fasting plasma total bile acid (a), total conjugated bile acid (b), and
total unconjugated bile acid (c) concentrations in sham and IT offspring.
++P<0.01 by two-way ANOVA, ***P<0.001 by Bonferroni’s posttest
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profiles in IT and sham offspring. IT offspring exhibited lower
circulating total and unconjugated bile acid concentrations com-
pared with sham offspring at 2 months of age. This difference in
circulating bile acid concentrations was no longer present at
3 months of age. Therefore, circulating bile acids do not appear
to play a major role in mediating the metabolic benefits of
maternal IT surgery. We hypothesize that circulating bile acid
concentrations were lower in IT offspring early in life possibly
because enzymes regulating bile acid synthesis had been
downregulated in utero due to exposure to higher maternal
circulating bile acid concentrations.
In conclusion, maternal IT surgery produces several meta-
bolic benefits, all of which are independent of maternal body
weight. Maternal IT surgery reduces body weight and im-
proves insulin secretion and nutrient-stimulated GLP-2 secre-
tion in offspring in the UCD-T2DM rat model of type 2
diabetes. Overall, these data suggest that the metabolic effects
of bariatric surgery likely confer metabolic benefits to off-
spring independently of changes of maternal body weight,
providing a potentially valuable model for the identification
and development of new preventative and therapeutic modal-
ities for obesity and type 2 diabetes. One shortcoming of this
study is the lack of more in-depth data collected on the dams.
We are making the assumption that the dams exhibit metabolic
outcomes similar to those previously observed in male UCD-
T2DM rats after ITsurgery [14, 19]. Furthermore, these results
suggest the need for additional and more comprehensive
studies, including identification of epigenetic and/or other
developmental factors involved in conferring metabolic ef-
fects of bariatric surgery to the next generation.
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